I was excited to participate in Allison Johnson’s recent Biocentury article reflecting on the growing interest of industry in allostery and why […]

I was excited to participate in Allison Johnson’s recent Biocentury article reflecting on the growing interest of industry in allostery and why […]
Most conventional small molecule drugs engage directly with the engine of a protein’s function, aiming to often turning off an […]
In the quest towards building high-performing teams, biopharma can lift a page from the tech playbook around agile organizations. This […]
Subscribe and get notified about new posts.